TRUST IN EXCELLENCE
Vifor Pharma Group, formerly Galenica Group, is a global pharmaceutical company that researches, develops, produces and markets its own pharmaceutical products and is the partner of choice for innovative, patient-focused solutions.
The Galenica Group will change its name into Vifor Pharma Group at the Annual General Meeting in May 2017, with the vision to become a Global Leader in Iron Deficiency, Nephrology and Cardio-Renal Therapies.
Relypsa, Inc., a Vifor Pharma Group company, is a biopharmaceutical company focused on the discovery, development and commercialisation of polymeric medicines for patients with conditions that are often overlooked and undertreated.
Vifor Pharma is a leader in iron deficiency therapy, with a history dating back to 1872 when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland, and developed infusion preparations and pharmaceutical specialities.
We have a broad and diversified offering in nephrology and cardio-renal therapies.
READ MORE: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA
Resources for media, including media releases, images and videos, financial and annual reporting, and more.
WORKING AT VIFOR PHARMA
Together we are making a difference: Finding new solutions, delivering high-quality products, driving scientific excellence and helping people around the world.
Download Half-year Report 2020 - Full Version (PDF)
Vifor Pharma Pty Ltd.,
Level 8, 80 Dorcas Street,
Southbank, Melbourne VIC 3006,
Phone: +61 39 686 01 11
By clicking on this link you are leaving the internet portal www.viforpharma.com.au and the scope of responsibility of Vifor Pharma Australia Limited. These websites have other terms and conditions of use and are subject to other standards/regulations and legislation.
To accept, click OK.